Abstract 4327: Progranulin (GP88) is an independent prognostic factor for prostate cancer patients
Helge Täubert(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Binbin Yue(University of Maryland, Baltimore), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Katrin Weigelt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Amer Abdulrahman(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann, Juan Guzman(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rudolf Jung(Universitätsklinikum Erlangen), Carol I. Geppert(Comprehensive Cancer Center Erlangen), Ginette Serrero(University of Maryland, Baltimore)
Cited by 0
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Toward the blood-borne miRNome of human diseases
|Nature Methods|2011|364
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258